Klotho Neurosciences, Inc.

KLTO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$6,150-$707-$599-$1,109
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,650$0$1$821
Change in WC$151$261-$2$4
Other Non-Cash$404$0$0$0
Operating Cash Flow-$2,947-$447-$600-$284
Investing Activities
PP&E Inv.-$123-$14-$125$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$38$0$0
Investing Cash Flow-$123$24-$125$0
Financing Activities
Debt Repay.$2,177$159-$9$0
Stock Issued$295$100$750$250
Stock Repurch.-$120$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$779$91-$241$0
Financing Cash Flow$3,131$350$500$250
Forex Effect$0$0$0$0
Net Chg. in Cash$61-$73-$225-$34
Supplemental Information
Beg. Cash$3$76$301$335
End Cash$64$3$76$301
Free Cash Flow-$3,070-$461-$725-$284